News
1h
AZoNano on MSNNew Bilayer Graphene Model Achieves Controllable SemiconductivityThis study presents a bilayer graphene model that regulates conductivity through controlled rotation, offering insights for ...
Juan Casado Cordón, Professor of Physical Chemistry at the University of Malaga, considers graphene—an infinite layer of ...
Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.
Putting hypersensitive quantum sensors in a living cell is a promising path for tracking cell growth and diagnosing ...
Researchers led by Maike Sander, Scientific Director of the Max Delbrück Center, have developed a vascularized organoid model of hormone secreting cells in the pancreas.
5d
Interesting Engineering on MSNLockheed uses IBM’s quantum processor to crack ‘open-shell’ puzzle in chemistryResearchers at IBM and Lockheed Martin teamed up high-performance computing with quantum computing to accurately model the ...
In a new paper published in The Journal of Chemical Theory and Computation, researchers from IBM Quantum and Lockheed Martin ...
HOUSTON, May 5, 2025 /PRNewswire/ -- Gretchen Watkins, President, Shell USA since July 1, 2018, will step down, effective July 31, 2025, after seven years in role. Colette Hirstius, currently ...
A deal between Shell and BP would be likely to attract intense political and regulatory scrutiny - David Paul Morris/Bloomberg Shell is considering a takeover of BP after the oil giant’s botched ...
‘Tis the week for small AI models, it seems. Nonprofit AI research institute Ai2 on Thursday released Olmo 2 1B, a 1-billion-parameter model that Ai2 claims beats similarly-sized models from ...
Contribution from the Department of Chemistry & Biochemistry ... The principles of SILAR were demonstrated by the CdSe/CdS core/shell model system using its shell-thickness-dependent optical spectra ...
A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime Therapeutics has emerged from stealth with $2.1 million in preseed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results